| |
NMES (n = 10)
|
RT (n = 10)
|
Control (n = 6)
|
|---|
| |
Week 1
|
Week 8
|
Week 14
|
Week 1
|
Week 8
|
Week 14
|
Week 1
|
Week 8
|
Week 14
|
|---|
|
Walk Test (s)
|
15.43±3.61
|
13.85±3.79*
|
13.08±4.08*
|
16.81±3.39
|
14.07±3.40*
|
14.50±3.71*
|
16.64±3.64
|
16.30±3.58
|
11.55±4.10
|
|
Chair Rise Test (s)
|
7.37±2.05
|
6.35±1.46*
|
5.79±1.20*
|
8.33±1.45
|
5.97±0.58*
|
6.18±1.05*
|
8.16±2.23
|
8.01±2.17
|
5.20±1.11
|
|
Stair Climb Test (s)
|
14.31±5.11
|
11.87±4.21*
|
12.48±6.44*
|
15.12±5.32
|
11.78±4.54*
|
11.84±5.03*
|
13.27±5.36
|
13.06±5.84
|
9.63±2.99
|
|
WOMAC Physical Function
|
41.04±11.60
|
33.88±12.66
|
31.50±12.63*
|
31.68±12.92
|
33.91±12.91
|
31.50±14.40
|
31.67±17.95
|
26.11±15.33
|
21.67±18.90
|
|
WOMAC Pain
|
11.50±3.50
|
8.88±3.29*
|
8.50±2.72
|
11.05±3.02
|
10.78±4.31
|
9.60±4.14
|
9.00±3.65
|
8.33±4.36
|
8.33±4.08
|
|
WOMAC Stiffness
|
5.17±2.17
|
3.92±2.15
|
4.10±2.18
|
5.23±0.68
|
4.73±1.74
|
4.45±2.24
|
5.22±1.72
|
4.11±1.83
|
4.00±2.37
|
|
SF-36 Physical Health
|
39.25±16.95
|
50.50±16.60*
|
47.60±10.73
|
39.73±16.51
|
50.00±23.12
|
53.20±25.09
|
51.78±24.34
|
56.00±24.74
|
67.83±21.71
|
|
SF-36 Mental Health
|
60.67±26.45
|
70.67±21.84
|
65.40±12.98
|
56.36±21.91
|
66.64±20.36
|
65.30±24.91
|
62.00±25.41
|
65.00±27.77
|
70.50±22.40
|
|
Isometric Peak Torque (Nm)
|
88.16±31.21
|
92.59±36.66
|
86.65±31.21
|
82.55±22.39
|
87.16±17.84
|
86.87±21.44
|
92.99±47.89
|
100.30±32.80
|
97.35±44.76
|
|
Isokinetic Peak Torque (Nm)
|
67.33±19.42
|
71.37±23.89
|
66.36±20.18
|
64.52±21.74
|
71.79±17.27
|
70.91±21.83
|
75.10±28.45
|
75.91±28.83
|
77.80±47.45
|
|
Quadriceps CSA (mm2)
|
4061±721
|
4279±784*
| |
4335±610
|
4521±651*
| | | | |
- Values are mean ± standard deviation.
- * P significant vs. week 1 (P < 0.0056).
- NMES, Neuromuscular Electrical Stimulation Group; RT, Resistance Training Group; WOMAC, Western Ontario McMaster Osteoarthritis index.
- SF-36, Short Form 36; CSA: Cross-sectional area.
